Chelsea works as a Manager of Clinical Supply Chain Operations who ensures clinical drug supply reaches patients in the gene therapy rare disease space for Biomarin. Having graduated with a BSc in Bioengineering from Lehigh University and a MSc in Biomedical Engineering from the University of Oklahoma, she earned her Project Management Professional (PMI-PMP) in 2019 and recently earned her MBA from Tennessee Technological University. She has held roles across Validation, Quality, and Project Management functions. Chelsea has been a member of ISPE since 2018 and is currently a committee member of ISPE-CASAs Emerging Leaders.
The pharmaceutical industry stands at the cusp of a transformative era, where the integration of sustainability within the supply chain is not just a trend, but a necessity. The 2024 ISPE Annual Meeting &...
The global pharmaceutical industry has faced unprecedented challenges in recent years, with the COVID-19 pandemic serving as a wake-up call for the vulnerabilities within the pharmaceutical supply chain. As the world strives to emerge from the grip of the pandemic and restore activities reminiscent of pre-pandemic times, uncertainties surrounding supply chain stability persist. The
Emerging Leaders (EL) within the pharmaceutical industry have been invited from around the world to participate in the 2022 ISPE Annual Meeting & Expo Program Committee. This unique opportunity allows...